Skip to content
2000
Volume 14, Issue 1
  • ISSN: 1871-5249
  • E-ISSN: 1875-6166

Abstract

A series of novel substituted quinazolin-4(3H)-one derivatives were synthesized and screened in vivo for their antihypertensive activities. Out of eighteen synthesized compounds, seven i.e. 2a, 2c, 4a, 4d, 5d, 6a & 6b compounds have shown hypotensive effect and produced bradycardia. These compounds have shown better activity than reference drug Prazosin (which acts as anti-hypertensive agent by α1 blocking action). All the compounds have shown ALD50>1000mg/kg with maximum in 2c & 4d (>1200mg/kg).

Loading

Article metrics loading...

/content/journals/cnsamc/10.2174/1871524914666140825144729
2014-04-01
2025-10-10
Loading full text...

Full text loading...

/content/journals/cnsamc/10.2174/1871524914666140825144729
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test